Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (13233)	8/13/1998 5:21:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

DaiS, Don't quite understand this company. We all know the fundamentals behind the company and its product. We know that the ED market is barely tapped on a world wide basis and that Vivus will thrive even with orals such as Viagra. The stock price has gone beyond absurd. Unfortuneatly perception is the rule of the market and the perception is that there is not enough room for both MUSE and Viagra. MUSE scripts are down substantially but it still has only been about 3 months that Viagra has been available. IMO the next 3 months will tell us a lot regarding what exactly is going on in the ED market regarding these two drugs. I just hope that Vivus doesn't end up as a hostile take over and we shareholders don't end up getting a lot less for our shares than we would have if more time was allowed to pass.

To: DaiS who wrote (13233)	8/13/1998 5:22:00 PM
From: Don Dunlap	Read Replies (1) \| Respond to of 23519

Viagra Reality Set In: Courtesy BIGKNY3 www3.techstocks.com We all knew this. The $64,000 question is why is Vivus incapable of establishing a market among Viagra failures? Personally, I don't see it happening. Script numbers would have turned by now.

To: DaiS who wrote (13233)	8/13/1998 5:24:00 PM
From: John W. Andrews	Respond to of 23519

THanks Dias on the gene therepy thing.....I did not buy the stock for that reason but if it is good I'll take it... I will have to rely on the physicians here to say if this Gene thing is good... Personally I would buy Vivus for the $150 million market cap ...of course if I had the money.. Pizzaman

To: DaiS who wrote (13233)	8/13/1998 6:07:00 PM
From: DAVID	Read Replies (1) \| Respond to of 23519

DaiS <<These two posts give what I know about the gene therapy work Message 5319236 Message 5416846; Excellent posts. If the gene therapy does work well, can anyone guess as to: 1) when clinicals might start, 2) how long would they take to complete, 3) what the clinicals might cost to do, 4) the cost of an injection every two months of an approved drug, and 5) the cost of the manufactured dose vivus would bear. I know those are hard questions to answer. I'm trying to figure them out myself. Does Vivus have the exclusive rights to the work done by the Albert E. researches ? Does anyone know the working arrangements ? DAVID